免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

The Fourth Left Atrial Appendage Occlusion Study

NCT:NCT05963698 · RECRUITING

NCT编号NCT05963698
状态RECRUITING
开始日期2023-11-30
完成时间2029-12-01
SponsorHamilton Health Sciences Corporation (OTHER)
First posted
Last updated

简要摘要

LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑